Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIRSNYSE:CORBFNASDAQ:SERAOTCMKTS:TNTY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIRSAirSculpt Technologies$4.83-1.4%$3.87$1.53▼$9.20$288.02M2.46270,442 shs348,819 shsCORBFGlobal Cord Blood$1.50$1.09$0.25▼$2.00$182.33M-0.66121,680 shs1,124 shsSERASera Prognostics$2.77-32.3%$2.21$1.37▼$9.13$154.08M0.72176,922 shs1.82 million shsTNTYTrue Nature$0.28-29.0%$0.34$0.02▼$0.11$24.24M2.99785,609 shs5,963 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIRSAirSculpt Technologies0.00%+2.73%+10.61%+109.40%+22.50%CORBFGlobal Cord Blood0.00%+27.12%+50.00%+66.67%+30.43%SERASera Prognostics0.00%+113.02%+158.04%+11.14%-30.91%TNTYTrue Nature0.00%-15.15%-6.95%-45.07%+126.90%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIRSAirSculpt Technologies0.777 of 5 stars1.00.00.00.03.35.00.0CORBFGlobal Cord BloodN/AN/AN/AN/AN/AN/AN/AN/ASERASera Prognostics1.553 of 5 stars0.04.00.00.03.82.50.0TNTYTrue NatureN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIRSAirSculpt Technologies 2.00Hold$3.75-22.36% DownsideCORBFGlobal Cord Blood 0.00N/AN/AN/ASERASera Prognostics 0.00N/AN/AN/ATNTYTrue Nature 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest TNTY, CORBF, SERA, and AIRS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/31/2025AIRSAirSculpt TechnologiesLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$6.50 ➝ $2.50(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIRSAirSculpt Technologies$180.35M1.57$0.17 per share29.22$1.37 per share3.53CORBFGlobal Cord Blood$196.12M0.93$1.07 per share1.40N/A∞SERASera Prognostics$80K1,304.32N/AN/A$1.40 per share1.98TNTYTrue NatureN/AN/AN/AN/A($0.03) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIRSAirSculpt Technologies-$8.25M-$0.30N/A∞N/A-9.95%-15.01%-5.85%8/8/2025 (Estimated)CORBFGlobal Cord Blood$79.04MN/A0.00∞N/AN/AN/AN/AN/ASERASera Prognostics-$32.90M-$0.94N/AN/AN/A-28,685.22%-51.35%-37.21%8/6/2025 (Estimated)TNTYTrue Nature-$3.88MN/A0.00∞N/AN/AN/A-13,987.90%N/ALatest TNTY, CORBF, SERA, and AIRS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025SERASera Prognostics-$0.24-$0.20+$0.04-$0.20$0.06 million$0.04 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIRSAirSculpt TechnologiesN/AN/AN/AN/AN/ACORBFGlobal Cord BloodN/AN/AN/AN/AN/ASERASera PrognosticsN/AN/AN/AN/AN/ATNTYTrue NatureN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIRSAirSculpt Technologies0.900.570.57CORBFGlobal Cord BloodN/AN/AN/ASERASera PrognosticsN/A2.022.02TNTYTrue NatureN/A0.040.04Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIRSAirSculpt Technologies91.54%CORBFGlobal Cord BloodN/ASERASera Prognostics54.64%TNTYTrue NatureN/AInsider OwnershipCompanyInsider OwnershipAIRSAirSculpt Technologies76.58%CORBFGlobal Cord Blood0.50%SERASera Prognostics15.80%TNTYTrue Nature30.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIRSAirSculpt Technologies24058.78 million13.77 millionOptionableCORBFGlobal Cord Blood1,200121.55 millionN/ANot OptionableSERASera Prognostics12037.67 million31.72 millionOptionableTNTYTrue Nature3086.57 millionN/ANot OptionableTNTY, CORBF, SERA, and AIRS HeadlinesRecent News About These CompaniesIs “Animal Kingdom” based on a true story? Meet the real-life crime family that inspired the hit showJune 17, 2025 | msn.comTop 20 actors who hate being famousNovember 14, 2024 | soapcentral.comSResilience in the face of nature: An Oklahoma rancher's daily struggle with the elementsNovember 14, 2024 | ktul.comKWhy is Jake Paul vs Mike Tyson on Netflix? What fight means for future of live sportNovember 13, 2024 | msn.comChinese man cycles across the US to ‘show that human nature is good'November 9, 2024 | nbclosangeles.comNInter vs Arsenal LIVE: Champions League result and reaction as Hakan Calhanoglu penalty proves decisiveNovember 7, 2024 | msn.comThe Completely Free Nature Center Hiding in an Oklahoma State Park Is a Must-VisitNovember 6, 2024 | onlyinyourstate.comOSouth Carolina women's basketball bold predictions includes national tile, SEC MVP MiLaysia FulwileyNovember 4, 2024 | greenvilleonline.comGInvest in ethical hunting and recreation for the true balance of natureNovember 3, 2024 | durangoherald.comDAI in wrong hands can cause annihilation beyond imagination, says WHO AdvisorNovember 3, 2024 | msn.comGeorge Ford misses two last-gasp kicks in England’s agonising defeat by New ZealandNovember 3, 2024 | telegraph.co.ukWhat is a Conservative? Understanding how the term works in American politicsNovember 1, 2024 | thenewstribune.comTTrump heads West for back-to-back rallies, Harris campaigns with Obama and Springsteen as race tightensOctober 30, 2024 | cbsnews.comKyrie Irving's expertise in key area shows why he's perfect for MavericksOctober 30, 2024 | msn.comThe best shows on Peacock right now (November 2024)October 30, 2024 | msn.comJulia Leigh’s The Hunter at 25: a ruthlessly unsentimental tale of nature betrayedOctober 29, 2024 | theconversation.comT10 Smallest Motorcycles You Can Buy In 2024October 27, 2024 | topspeed.comT“Disrespectful”: Charles Barkley Falls Prey to Public Scrutiny After Honest Shai Gilgeous-Alexander TakeOctober 26, 2024 | msn.comWant genuine progress toward restoring nature? Follow these four stepsOctober 26, 2024 | msn.comWhat will be the next chapter of Justin Brownlee's legend?October 24, 2024 | espn.inENew MarketBeat Followers Over TimeMedia Sentiment Over TimeTNTY, CORBF, SERA, and AIRS Company DescriptionsAirSculpt Technologies NASDAQ:AIRS$4.83 -0.07 (-1.43%) As of 04:00 PM EasternAirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.Global Cord Blood NYSE:CORBF$1.50 0.00 (0.00%) As of 01:06 PM EasternGlobal Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.Sera Prognostics NASDAQ:SERA$2.77 -1.32 (-32.27%) As of 04:00 PM EasternSera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.True Nature OTCMKTS:TNTY$0.28 -0.11 (-29.04%) As of 06/27/2025True Nature Holding, Inc. focuses on engaging in compounding pharmacy activities direct to consumers, doctors, and veterinary professionals. It also focuses on the development of software applications in the healthcare arena, including telemedicine; and consideration of services offering using blockchain encryption technology for various aspects of the healthcare industry. The company is based in Atlanta, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Why BigBear.ai Could Rally 100% and Catch Palantir Soon Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Alphabet’s Waymo and Services Beginning to Feel the Pressure? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
